The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs
Open accessAbstract
Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is an important cause of preventable mortality and morbidity. In this study, we summarize estimates of per-patient and aggregate medical costs or expenditures attributable to incident VTE in the United States. Per-patient estimates of incremental costs can be calculated as the difference in costs between patients with and without an event after controlling for differences in underlying health status. We identified estimates of the incremental per-patient costs of acute VTEs and VTE-related complications, including recurrent VTE, post-thrombotic syndrome, chronic thromboembolic pulmonary hypertension, and anticoagulation-related adverse drug events. Based on the studies identified, treatment of an acute VTE on average appears to be associated with incremental direct medical costs of $12,000 to $15,000 (2014 US dollars) among first-year survivors, controlling for risk factors. Subsequent complications are conservatively estimated to increase cumulative costs to $18,000–23,000 per incident case. Annual incident VTE events conservatively cost the US healthcare system $7–10 billion each year for 375,000 to 425,000 newly diagnosed, medically treated incident VTE cases. Future studies should track long-term costs for cohorts of people with incident VTE, control for comorbid conditions that have been shown to be associated with VTE, and estimate incremental medical costs for people with VTE who do not survive. The costs associated with treating VTE can be used to assess the potential economic benefit and cost-savings from prevention efforts, although costs will vary among different patient groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Morbidity and Mortality Weekly Report
(2011) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2010.11.007 · Cited by 3,423
Goldhaber, S. Z., Visani, L., & De Rosa, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07534-5 · Cited by 2,870
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,360
Rao, S. V., & Jollis, J. G. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.10.991 · Cited by 2,217
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
Pengo, V., Lensing, A. W. A., Prins, M. H., Marchiori, A., Davidson, B. L., Tiozzo, F., Albanese, P., Biasiolo, A., Pegoraro, C., Iliceto, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032274 · Cited by 1,828
Cost-Effectiveness in Health and Medicine
(2016) · doi:10.1093/acprof:oso/9780190492939.001.0001 · Cited by 1,552
Incidence and mortality of venous thrombosis: a population‐based study
NÆSS, I. A., CHRISTIANSEN, S. C., ROMUNDSTAD, P., CANNEGIETER, S. C., ROSENDAAL, F. R., & HAMMERSTRØM, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02450.x · Cited by 1,413
Epidemiology of venous thromboembolism
Heit, J. A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.83 · Cited by 1,277
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
Hooper, C., Laurence, I., Harvey, J., Morley, A., Darby, M., Edey, A., & Maskell, N. (2014) · Respiration · doi:10.1159/000347003 · Cited by 1,184
Writing Committee Members, McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192230 · Cited by 1,093
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis
Kahn, S. R., Shrier, I., Julian, J. A., Ducruet, T., Arsenault, L., Miron, M.-J., Roussin, A., Desmarais, S., Joyal, F., Kassis, J., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00004 · Cited by 854
Incidence of Venous Thromboembolism: A Community-based Study in Western France
Oger, E., & the EPI-GETBO Study Group (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613887 · Cited by 711
Baglin, T., Luddington, R., Brown, K., & Baglin, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14111-6 · Cited by 694
METHODS FOR ANALYZING HEALTH CARE UTILIZATION AND COSTS
Diehr, P., Yanez, D., Ash, A., Hornbrook, M., & Lin, D. Y. (1999) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.20.1.125 · Cited by 663
The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
Rathbun, S. (2009) · Circulation · doi:10.1161/circulationaha.108.841403 · Cited by 575
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
Kahn, S. R., Shapiro, S., Wells, P. S., Rodger, M. A., Kovacs, M. J., Anderson, D. R., Tagalakis, V., Houweling, A. H., Ducruet, T., Holcroft, C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61902-9 · Cited by 524
SCHULMAN, S., LINDMARKER, P., HOLMSTRÖM, M., LÄRFARS, G., CARLSSON, A., NICOL, P., SVENSSON, E., LJUNGBERG, B., VIERING, S., NORDLANDER, S., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01795.x · Cited by 507
Thrombosis: a major contributor to the global disease burden
Raskob, G. E., Angchaisuksiri, P., Blanco, A. N., Buller, H., Gallus, A., Hunt, B. J., Hylek, E. M., Kakkar, A., Konstantinides, S. V., McCumber, M., et al. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12698 · Cited by 484
Self-citationTagalakis, V., Patenaude, V., Kahn, S. R., & Suissa, S. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.02.024 · Cited by 463
Venous thromboembolism: disease burden, outcomes and risk factors
HEIT, J. A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01415.x · Cited by 447
Becattini, C., Agnelli, G., Pesavento, R., Silingardi, M., Poggio, R., Taliani, M. R., & Ageno, W. (2006) · Chest · doi:10.1378/chest.130.1.172 · Cited by 414
Risk Factors for Venous Thromboembolism: Results From the Copenhagen City Heart Study
Holst, A. G., Jensen, G., & Prescott, E. (2010) · Circulation · doi:10.1161/circulationaha.109.921460 · Cited by 396
Cost of illness studies: What is good about them?
Rice, D. P. (2000) · Injury Prevention · doi:10.1136/ip.6.3.177 · Cited by 349
Spyropoulos, A. C., & Lin, J. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.6.475 · Cited by 328
Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome
MacDougall, D. A., Feliu, A. L., Boccuzzi, S. J., & Lin, J. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060388 · Cited by 300
Secular Trends in Occurrence of Acute Venous Thromboembolism: The Worcester VTE Study (1985-2009)
Huang, W., Goldberg, R. J., Anderson, F. A., Kiefe, C. I., & Spencer, F. A. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.03.041 · Cited by 297
Incidence and cost burden of post-thrombotic syndrome
Ashrani, A. A., & Heit, J. A. (2009) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-009-0309-3 · Cited by 295
Post‐thrombotic syndrome: prevalence, prognostication and need for progress
Prandoni, P., & Kahn, S. R. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07601.x · Cited by 279
Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
Kearon, C., & Akl, E. A. (2014) · Blood · doi:10.1182/blood-2013-12-512681 · Cited by 279
Risk assessment for recurrent venous thrombosis
Kyrle, P. A., Rosendaal, F. R., & Eichinger, S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60962-2 · Cited by 261
Klok, F. A., van Kralingen, K. W., van Dijk, A. P. J., Heyning, F. H., Vliegen, H. W., & Huisman, M. V. (2010) · Haematologica · doi:10.3324/haematol.2009.018960 · Cited by 258
Bergqvist, D., Jendteg, S., Johansen, L., Persson, U., & Odegaard, K. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-6-199703150-00006 · Cited by 252
Administrative and Claims Records as Sources of Health Care Cost Data
Riley, G. F. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819c95aa · Cited by 251
Miniati, M., Monti, S., Bottai, M., Scoscia, E., Bauleo, C., Tonelli, L., Dainelli, A., & Giuntini, C. (2006) · Medicine · doi:10.1097/01.md.0000236952.87590.c8 · Cited by 251
Prevalence of clinical venous thromboembolism in the USA: Current trends and future projections
Deitelzweig, S. B., Johnson, B. H., Lin, J., & Schulman, K. L. (2011) · American Journal of Hematology · doi:10.1002/ajh.21917 · Cited by 244
Triggers of Hospitalization for Venous Thromboembolism
Rogers, M. A. M., Levine, D. A., Blumberg, N., Flanders, S. A., Chopra, V., & Langa, K. M. (2012) · Circulation · doi:10.1161/circulationaha.111.084467 · Cited by 231
Mohr, D. N., Silverstein, M. D., Heit, J. A., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.12.1249 · Cited by 205
Venous Thromboembolism in Adult Hospitalizations—United States, 2007–2009
(2012) · JAMA · doi:10.1001/jama.308.6.559 · Cited by 203
Venous Thromboembolism Risk in Patients With Cancer Receiving Chemotherapy: A Real-World Analysis
Lyman, G. H., Eckert, L., Wang, Y., Wang, H., & Cohen, A. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0226 · Cited by 194
Caprini, J. A., Botteman, M. F., Stephens, J. M., Nadipelli, V., Ewing, M. M., Brandt, S., Pashos, C. L., & Cohen, A. T. (2003) · Value in Health · doi:10.1046/j.1524-4733.2003.00204.x · Cited by 182
GUANELLA, R., DUCRUET, T., JOHRI, M., MIRON, M. ‐., ROUSSIN, A., DESMARAIS, S., JOYAL, F., KASSIS, J., SOLYMOSS, S., GINSBERG, J. S., et al. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04516.x · Cited by 177
Venous Thromboembolism (VTE) in Patients with Cancer: Epidemiology and Risk Factors
Wun, T., & White, R. H. (2009) · Cancer Investigation · doi:10.1080/07357900802656681 · Cited by 171
Borrego, M. E., Woersching, A. L., Federici, R., Downey, R., Tiongson, J., Bieniarz, M. C., Cavanaugh, B. J., Spyropoulos, A. C., & Mahan, C. E. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0162 · Cited by 167
Economic burden of venous thromboembolism: a systematic review
Ruppert, A., Steinle, T., & Lees, M. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2010.546465 · Cited by 155
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism
Dentali, F., Donadini, M. P., Gianni, M., Bertolini, A., Squizzato, A., Venco, A., & Ageno, W. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.01.003 · Cited by 150
Khorana, A. A., Dalal, Lin, & Connolly (2013) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s39964 · Cited by 140
Bullano, M. F., Willey, V. J., Hauch, O., Wygant, G. D., Spyropoulos, A. C., & Hoffman, L. (2005) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2005.11.8.663 · Cited by 131
The Impact of Medical Errors on Ninety‐Day Costs and Outcomes: An Examination of Surgical Patients
Encinosa, W. E., & Hellinger, F. J. (2008) · Health Services Research · doi:10.1111/j.1475-6773.2008.00882.x · Cited by 126
Brækkan, S. K., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Störmer, J., & Hansen, J.-B. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03102.x · Cited by 122
Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer
Connolly, G. C., Dalal, M. R., Lin, J., & Khorana, A. A. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.09.007 · Cited by 118
Management of Acute Proximal Deep Vein Thrombosis
Spyropoulos, A. C., Hurley, J. S., Ciesla, G. N., & de Lissovoy, G. (2002) · CHEST Journal · doi:10.1378/chest.122.1.108 · Cited by 117
Christensen, L., Sasané, R., Hodgkins, P., Harley, C., & Tetali, S. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003673617 · Cited by 94
Louzada, M., Majeed, H., Dao, V., & Wells, P. S. (2011) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328341f030 · Cited by 90
McGarry, L. J., Thompson, D., Weinstein, M. C., & Goldhaber, S. Z. (2004) · PubMed · Cited by 85
Overview of Methods to Estimate the Medical Costs of Cancer
Barlow, W. E. (2009) · Medical Care · doi:10.1097/mlr.0b013e3181a2d847 · Cited by 79
Comparison of Approaches for Estimating Incidence Costs of Care for Colorectal Cancer Patients
Yabroff, K. R., Warren, J. L., Schrag, D., Mariotto, A. B., Meekins, A., Topor, M. A., & Brown, M. L. (2009) · Medical Care · doi:10.1097/mlr.0b013e3181a4f482 · Cited by 78
Deep-vein thrombosis: A United States cost model for a preventable and costly adverse event
Holdsworth, M. T., Welch, S. M., Borrego, M., Spyropoulos, A. C., & Mahan, C. E. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-02-0132 · Cited by 76
Lefebvre, P., Coleman, C. I., Bookhart, B. K., Wang, S.-T., Mody, S. H., Tran, K. N., Zhuo, D. Y., Huynh, L., & Nutescu, E. A. (2014) · Journal of Medical Economics · doi:10.3111/13696998.2013.858634 · Cited by 66
The humanistic and economic burden of venous thromboembolism in cancer patients: a systematic review
Kourlaba, G., Relakis, J., Mylonas, C., Kapaki, V., Kontodimas, S., Holm, M. V., & Maniadakis, N. (2014) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000193 · Cited by 58
Copher, R. M., Cerulli, A., Watkins, A. K., & Monsalvo, M. L. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.690801 · Cited by 55
Direct Medical Cost of Managing Deep Vein Thrombosis According to the Occurrence of Complications
O’Brien, J. A., & Caro, J. J. (2002) · PharmacoEconomics · doi:10.2165/00019053-200220090-00004 · Cited by 53
Lefèbvre, P., Laliberté, F., Nutescu, E. A., Duh, M. S., LaMori, J. C., Bookhart, B., Olson, W. H., Dea, K., Schein, J. R., & Kaatz, S. (2012) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2012.18.5.363 · Cited by 53
Otero, R., Oribe, M. A., Ballaz, A., Jiménez, D., Uresandi, F., Nauffal, D., Conget, F., Rodríguez, C., Elías-Hernández, T., Jara‐Palomares, L., et al. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2010.12.010 · Cited by 47
Identifying Risk Factors for Venous Thromboembolism
White, R. H. R. (2012) · Circulation · doi:10.1161/circulationaha.112.102814 · Cited by 39
Amin, A., Bruno, A. S., Trocio, J. N., Lin, J., & Lingohr-Smith, M. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1007210 · Cited by 37
Başer, O., Supina, D., Sengupta, N., Wang, L., & Kwong, L. M. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090572 · Cited by 30
Poli, D., & Miniati, M. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328349289a · Cited by 28
Kirson, N. Y., Birnbaum, H. G., Ivanova, J. I., Waldman, T., Joish, V. N., & Williamson, T. E. (2011) · Applied Health Economics and Health Policy · doi:10.2165/11592440-000000000-00000 · Cited by 27
All-cause and disease-related health care costs associated with recurrent venous thromboembolism
Lefèbvre, P., Nutescu, E. A., Duh, M. S., LaMori, J. C., Bookhart, B., Olson, W. H., Dea, K., Hossou, Y., Schein, J. R., Kaatz, S., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-05-0425 · Cited by 21
Advancing the Science of Health Care Costing
Lipscomb, J., Barnett, P. G., Brown, M. L., Lawrence, W., & Yabroff, K. R. (2009) · Medical Care · doi:10.1097/mlr.0b013e3181a9d366 · Cited by 21
Preditores de hipertensão pulmonar após tromboembolia pulmonar de risco intermédio a elevado
Barros, A., Baptista, R., Nogueira, A., Jorge, E., Teixeira, R. P., Castro, G., Monteiro, P. F., & Providência, L. A. (2013) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2013.02.008 · Cited by 15
Johnson, S. G., Delate, T., Boka, A., Shaw, P. B., & Zager, C. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.849713 · Cited by 13
Chronic Thromboembolic Pulmonary Hypertension: Medical Treatment
Özsu, S., & Çınarka, H. (2013) · Pulmonary Circulation · doi:10.4103/2045-8932.114761 · Cited by 13
Predictors of pulmonary hypertension after intermediate-to-high risk pulmonary embolism
Barros, A., Baptista, R., Nogueira, A., Jorge, E., Teixeira, R. P., Castro, G., Monteiro, P. F., & Providência, L. A. (2013) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2013.10.027 · Cited by 8
Kreidy, R. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613497423 · Cited by 3
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Metadata
- Authors
- Grosse, S. D., Nelson, R. E., Nyarko, K. A., Richardson, L. C., & Raskob, G. E.
- Venue
- Thrombosis Research
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 137
- Pages
- 3-10
- ISSN
- 0049-3848 (ISSN-L)
- OpenAlex
- W2180762426
- Cited by
- 548
- References
- 78
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.